1. Home
  2. RDY vs VICR Comparison

RDY vs VICR Comparison

Compare RDY & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • VICR
  • Stock Information
  • Founded
  • RDY 1984
  • VICR 1981
  • Country
  • RDY India
  • VICR United States
  • Employees
  • RDY N/A
  • VICR N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • VICR Industrial Machinery/Components
  • Sector
  • RDY Health Care
  • VICR Technology
  • Exchange
  • RDY Nasdaq
  • VICR Nasdaq
  • Market Cap
  • RDY 2.5B
  • VICR 2.6B
  • IPO Year
  • RDY N/A
  • VICR N/A
  • Fundamental
  • Price
  • RDY $14.81
  • VICR $56.60
  • Analyst Decision
  • RDY Buy
  • VICR Hold
  • Analyst Count
  • RDY 1
  • VICR 2
  • Target Price
  • RDY $17.00
  • VICR $43.00
  • AVG Volume (30 Days)
  • RDY 1.9M
  • VICR 186.5K
  • Earning Date
  • RDY 01-23-2025
  • VICR 02-20-2025
  • Dividend Yield
  • RDY 3.89%
  • VICR N/A
  • EPS Growth
  • RDY 4.63
  • VICR N/A
  • EPS
  • RDY 0.76
  • VICR 0.10
  • Revenue
  • RDY $3,579,112,656.00
  • VICR $355,544,000.00
  • Revenue This Year
  • RDY $16.39
  • VICR N/A
  • Revenue Next Year
  • RDY $8.74
  • VICR $10.70
  • P/E Ratio
  • RDY $19.50
  • VICR $564.21
  • Revenue Growth
  • RDY 12.37
  • VICR N/A
  • 52 Week Low
  • RDY $13.52
  • VICR $30.90
  • 52 Week High
  • RDY $16.89
  • VICR $61.05
  • Technical
  • Relative Strength Index (RSI)
  • RDY 42.14
  • VICR 64.58
  • Support Level
  • RDY $14.74
  • VICR $46.17
  • Resistance Level
  • RDY $14.94
  • VICR $49.84
  • Average True Range (ATR)
  • RDY 0.20
  • VICR 2.07
  • MACD
  • RDY -0.12
  • VICR 0.60
  • Stochastic Oscillator
  • RDY 7.32
  • VICR 95.95

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About VICR Vicor Corporation

Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, advanced power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. Geographically, it derives a maximum of its revenue from the Asia Pacific.

Share on Social Networks: